international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress



Speaking Proposals | Promotional Opportunities | Grantors & Exhibitors | Travel/Hotel
Registration | Admininstration | Webcast Log In | Past Conferences | Contact Us | Home





TENTH INTERNATIONAL PHARMACEUTICAL COMPLIANCE CONGRESS

May 10 - 12, 2016

ATTEND ONSITE
WEBCAST ATTENDANCE
Hilton Warsaw Hotel and Convention Centre
Warsaw, Poland
In your own office or home live via the Internet with 24/7 access for 6 months
KEYNOTE SPEAKERS

Sadek Beloucif, MD
Professor, Department of Anesthesiology and Critical Care Medicine, Avicenne University Hospital, Chairman, Ethics Committee of the Biomedicine Agency, Paris, France

Hui Chen, JD
Compliance Counsel Expert, US Department of Justice, Former Global Head, Anti-Bribery and Corruption, Standard Chartered Bank, Former Assistant General Counsel, Pfizer, Washington, DC, USA

Peter Dieners, Esq.
Partner and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Co-chair, Legal Affairs Focus Group (LA FG), EUCOMED, Co-chair, Compliance Network (CN), EUCOMED, Düsseldorf, Germany

Gejaa Gobena, JD
Chief, Health Care Fraud Unit, US Department of Justice, Washington, DC, USA

Ewa Grenda
Chief Executive Officer, Poland Roche, President, INFARMA, Warsaw, Poland

Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain

Dr. Grzegorz Makowski, PhD
Director of the Public Integrity Program, Stefan Batory Foundation, the Transparency International Chapter in Poland, Assistant Professor, Collegium Civitas, Warsaw, Poland

Sophie Peresson
Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, London, UK

Marie-Claire Pickaert
Deputy Director General and Chief Financial Officer, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Heather Simmonds
Director, Prescription Medicines Code of Practice Authority, London, UK

Pawel Sztwiertnia
Chief Executive Officer, Employers' Union of Innovative Pharmaceutical Companies (INFARMA), Former Undersecretary of State, Polish Ministry of Health, Warsaw, Poland

CHIEF COMPLIANCE OFFICERS

Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma plc, Former VP, Chief Compliance Officer, Dendreon, Former Associate General Counsel and Executive Director of Compliance, Seattle Genetics, Chicago, IL, USA

Dante Beccaria
Global Compliance Officer and Vice President, Sanofi, Former Vice President of Internal Audit, Sanofi, Paris, France

Eric Cornut, LLM
Chief Ethics, Compliance & Policy Officer, Novartis, Former Chief Commercial Officer, Novartis, Basel, Switzerland

Martin Fürle, MBA (Berlin)
General Counsel and Chief Compliance Officer, Vice President Risk & Compliance, Daiichi Sankyo Europe GmbH, Munich, Germany

Marc-Olivier Lamaro
Chief Compliance Officer, Sanofi Pasteur MSD, Former Director, Compliance Officer, Johnson & Johnson, Lyon, France

Lori V. Queisser
Senior Vice President and Global Compliance Officer, Teva Pharmaceuticals, Former Sr. VP Global Compliance and Business Practices, Schering-Plough, Former Vice President and Chief Compliance Officer, Eli Lilly, Philadelphia, PA, USA

Uffe Kåre Rasmussen, M.Sc.
Senior Director and Chief Compliance Officer, H. Lundbeck A/S, Former Principal Scientist, Novo Nordisk A/S, Copenhagen, Denmark

Ashley Watson, Esq.
Senior Vice President, Chief Ethics & Compliance Officer, Merck Sharp Dohme (MSD), Former Counsel, Chief Ethics and Compliance Officer, Hewlett-Packard, Philadelphia, PA, USA

GLOBAL ANTICORRUPTION UPDATE

Ted Acosta, Esq.
Americas Vice Chair, Risk Management and Global Leader, Life Sciences, Fraud Investigation and Dispute Services, EY, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France

Cristian Ducu, PhD
Founder and General Manager, Centre for Advanced Research in Management and Applied Ethics, Member, National Bioethics Commission of the National Commission of Romania for UNESCO, Founding Member, Research Centre in Applied Ethics, Faculty of Philosophy, University of Bucharest, Bucharest, Romania

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA

Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, United States Department of Justice, Washington, DC, USA

Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia

Vivian Robinson, Esq.
Queen's Counsel, Partner, McGuire Woods, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Treasurer of Inner Temple, London, UK

THE NEW PHARMA MARKETPLACE

Patrick Delavault, MD
Senior Vice President, Chief Medical Officer, Global Medical & Regulatory Sciences, Ipsen, Paris, France

Frank Wartenberg, PhD
President, Central Europe, IMS Health, Frankfurt/Main, Germany

Andrew White
Head of Medicine Management - NHS, Greater Manchester Commissioning Support Unit, Manchester, UK

Olivier Wong
Consultant, Early Engagement, HTA Technology Transfer, MediQualité Omega, Former Voting Member, French Transparency Committee, Former French Guidelines Committee Member (HAS, ANSM), Paris, France

PLENARY SESSIONS
  • Overview of the EU, CEE and MEA Anti-Corruption Landscape
  • The National Anti-Corruption Strategy of Romania
  • US Department of Justice Anti-Corruption Update
  • Anti-Corruption Roundtable: Strategies to Foster Compliance
  • Challenges in the New Marketplace 2.0 Ethics and the Current Industry-Physician Relationship Models
  • EFPIA Keynote: Reflections on the Eve of Transparency
  • Perspectives on Transparency from Poland
  • Transparency International Keynote
  • Chief Compliance Officer Roundtable
  • Report from Compliance Survey Commissioned by Ethics
  • Updates on Global Codes
INTERNATIONAL PHARMA
CONGRESS IS

MINI SUMMITS
  • Examining an Investigation from All Sides
  • Annual CEE Compliance Update
  • New Strategies for Integrated Assessment and Management of Risks
  • Patient Programs - Managing Risks of Getting Closer to the Patient
  • Annual MEA Compliance Update
  • Contracting with Third Parties and Optimizing the Relationship
  • Introduction of a New Product into the New Marketplace
  • Data Privacy Case Study: Transferring Data Post the EJC Safe Harbour Ruling
  • Cultural Implications of Compliance Programs across Different Countries
  • Using Predictive Analytics to Enhance Risk Management
  • Third Party Relationships: Cross-Border Engagements, FMV, Monitoring and Auditing
  • New Ethics-Based Approaches to Policies and Training
  • Medical Devices: The Changing Enforcement Landscape
  • R&D Compliance: Case Study on Clinical Trial Data Disclosures
  • Using the Data to Provide Value and Partner with the Business

FEATURED FACULTY

Yogesh Bahl, CPA, MBA
Managing Director, Alix Partners, New York, NY

Marc Bartel, LLM, MBA
Managing Partner France, Partner, Legal and Board Practices, Heidrick & Struggles, Paris, France

Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY

Ela Bochenek, Esq.
Vice President, Global Compliance, Insmed Incorporated, Bridgewater, NJ, USA

Olivier Chaduteau
Managing Partner, Day One, Mentor for Entrepreneurs, IME (French Chamber of Commerce), Lecturer, Sciences Po Law School, Paris, France

Kip Ebel, MBA
Principal, Fraud Investigation & Dispute Services, EY, New York, NY, USA

Pierre E. Dupourque, JD
Assistant General Counsel, Regional Compliance Lead EMEA, Canada, Pakistan, India, Pfizer, Mannheim, Germany

Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

George Fife
Executive Director, Fraud Investigation & Dispute Services, EY, Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France

Cécile Gousset
Associate Vice President, Compliance Risk Assessment, Education and Monitoring, Global Ethics & Business Integrity, Sanofi, Paris, France

Ulf H. Grundmann
Partner, Life Science Practice Group, King & Spalding LLP, Frankfurt am Main, Germany

Carl Judge
Director, Fraud Investigation & Dispute Services, EY, London, UK

Anita K. Kim-Reinartz
Partner, Fraud Investigation & Dispute Services, EY, Düsseldorf, Germany

Isaure Kergall-Gayet
Compliance and Business Integrity Director France, Sanofi, Members, Strategic Committee, ETHICS, Former Vice President, Chief Ethics and Compliance Officer, Ipsen, Paris, France

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC

Tomasz Kruk, MBA, LLM
Head of Compliance, Vifor Pharma, Former Director International Compliance, Mallinckrodt Pharmaceuticals, Former Director Global Ethics & Compliance, Actavis plc (now Allergan plc), Zürich, Switzerland

Edoardo Lazzarini, PhD
Compliance Initiative Director EUCAN, Takeda Pharmaceuticals International, Former Compliance Officer EMEA (Europe, Middle East & Africa), Zimmer Biomet, Milano, Italy

Evelyne Lemaire, MA
Head of Compliance, Europe & Canada, Takeda Pharmaceuticals International GmbH, Zurich, Switzerland

Christine Longawa, CPA, CFE
Associate Director, Healthcare & Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant Consulting, Inc.. Chicago, IL, USA

Maurits J.F. Lugard, MA, JD, LLM
Partner and Lead, EU Life Sciences Regulatory Team, Sidley Austin LLP, Former Member of the European Commission's Legal Service, Brussels, Belgium

Abdul Luheshi, MBA
Director, Life-Sciences, Regulatory Compliance, KPMG UK LLP, Former Vice President, Health Care Compliance, Johnson & Johnson, Former Co-chair, Asia Pacific Pharma Compliance Congress, London, UK

Daniela Fabian Masoch, Esq.
Founder and Managing Director, Fabian Privacy Legal GmbH, Member and Chapter Co-Chair, International Privacy Professionals Association (IAPP), Former Global Head Data Privacy, Novartis International AG, Basel, Switzerland

Maureen McGirr, Esq.
Vice President Office of Ethics, Global Compliance Organization, Merck Sharp Dohme (MSD), Philadelphia, PA, USA

Laura Nassar
Head of Compliance, Middle East, Hoffmann-La Roche Ltd., Dubai, UAE

John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA

David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles, Board Member, ETHICS, Former Vice President Compliance, International Pharmaceuticals, GSK, Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK



Panagiota Giota Papamarkou
Ethics and Compliance Director, Global, Ipsen, Paris, France

Piergiorgio Pepe, LLM
EEMEA Compliance Area Director, Office of Ethics and Compliance, AbbVie, Former Director, Compliance and Ethics, EMEA, Bristol-Myers Squibb, Paris, France

Ariadna Quesada, MPP
Compliance Manager Europe, Middle-East, and Africa, MicroPort Orthopedics Inc., Amsterdam, Netherlands

Nathalie Raynaud
Corporate Compliance Officer, Ethics & Business Integrity Department, Sanofi, Paris, France

Daniel Schafaghi
Global Compliance Operating Officer, Head of Compliance Emerging Markets, Boehringer Ingelheim GmbH, Ingelheim, Germany

Agata Szeliga, LLM
Partner, Soltysinski, Kawecki and Szelzak, Warsaw, Poland

Michele Tagliaferri, Esq.
Partner, Sidley Austin LLP, Brussels, Belgium

Melda Tanyeri, MS, MBA
Director, Fraud Investigation & Dispute Services, EY, London, UK

Dr. Mirjam Weisse, JD
Senior Director, Head of Compliance EMEA, Merz Pharma GmbH & Co, KGaA, Frankfurt, Germany

Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland

Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium

Jolanta Wyszynska
Vice President Compliance Europe, AstraZeneca, Warsaw, Poland

Milena Yakimova, LLM
Director Ethics & Compliance, Central and South East Europe, Allergan, Sofia, Bulgaria


SPEAKER PRESENTATION PROPOSALS
Speaker/Presentation Proposals for the International Pharma Congress May Be Submitted Through Our Online Form
- Click Here -
SPONSORED BY:


CO-SPONSORS:




CO CHAIRS

Dr. Michael Bartke
Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Munich, Germany

Ann Beasley
Chief Compliance Officer, Biogen, Former Global Compliance Officer, Novartis Pharma AG, Board Member and Co-chair, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Cambridge, MA, USA

Stephen Nguyen Duc
Office of Ethics & Compliance Area Director, International Operations, Western Europe & Canada, AbbVie, Board Member, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Rungis, France

Dominique Laymand, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Ipsen; President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Roeland Van Aelst
Regional Vice President - HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium

GRANTORS:
DIAMOND


SILVER


BRONZE




















FOLLOW INTERNATIONAL PHARMA CONGRESS ON




Tweet using #PharmaCongress

OTHER INTERNATIONAL PHARMA CONGRESSES

2007 - Brussels


2008 - Paris


2009 - Rome


2010 - Berlin


2011 - Istanbul


2011 - Singapore


2012 - Budapest


2012 - Shanghai


2012 - São Paulo


2013 - Madrid, Spain


2013 - Kuala Lumpur


2014 - Dubai


2014 - Mexico City


2014 - Shanghai


2015 - Manila




PARTICIPATION OPTIONS
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction





We subscribe to the HONcode principles of the HON Foundation. Click to verify.




LIVE AND ARCHIVED WEBCAST ATTENDANCE
Watch the conference in live streaming video of plenary sessions and listen to audio of preconference and track sessions over the Internet and at your convenience at any time 24/7 for six months following the event.

The archived conference includes speaker Video and Audio and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for the next six months; accessible in the office, at home or anywhere worldwide with Internet access; avoid travel expense and hassle; no time away from the office.





WEBCAST INTERFACE SAMPLE

Click here for a sample stream

2016 GLOBAL PHARMA COMPLIANCE CONGRESSES

SEVENTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Transformational Learning - Effective Knowledge Exchange
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
October 19 - 21, 2016
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
SIXTH ASIA PACIFIC
PHARMACEUTICAL
COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Media Partners: Life Sciences Compliance Update
September 21 - 23, 2016
Shangri-La Hotel
Singapore
www.AsianPharmaCongress.com
PHARMACEUTICAL SUMMIT ON BUSINESS AND COMPLIANCE ISSUES IN MANAGED MARKETS
The Leading Forum on Pharmaceutical Market Access, Reimbursement, Pricing, and Contracting with Commercial and Government Payers
Co-located with Eighth National Medical Home, Sixth Bundled Payment Summit and Seventh National ACO Summit
Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
June 8 - 9, 2016
Grand Hyatt
Washington, DC
www.PharmaManagedMarketsSummit.com

THE 2015 NINTH INTERNATIONAL PHARMA CONGRESS CONTENT IS NOW AVAILABLE
IN VARIOUS POST CONFERENCE FORMATS

The 2015 Ninth International Pharma Congress conference content is now available in a variety of formats.

You may purchase the Congress streaming content in the following formats: Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format.

YOU CAN PURCHASE JUST THE INTERNATIONAL PHARMA CONGRESS CONTENT AS FOLLOWS:

Online Archive of 2015 Ninth International Pharma Congress Presentations today!
Complete conference: $595
Order Now

Flash Drive of 2015 Ninth International Pharma Congress Presentations today!
$595
Order Now

FINALLY YOU MAY PURCHASE INTERNATIONAL PHARMA CONGRESS INDIVIDUAL PRESENTATIONS:
Click here to purchase individual presentations for $59.95 in online archive format (6 months of access - 24/7).





Speaking Proposals | Promotional Opportunities | Grantors & Exhibitors | Travel/Hotel
Registration | Admininstration | Webcast Log In | Past Conferences | Contact Us | Home




© Health Care Conference Administrators
Contact Webmaster